July 7, 2014 / 11:25 AM / in 3 years

Endo, BioDelivery painkiller effective in late-stage study

July 7 (Reuters) - Endo International Plc and BioDelivery Sciences International Inc said their experimental pain drug was found effective in a late-stage trial.

The painkiller, BEMA buprenorphine, was being tested against a placebo in patients with pain severe enough to require around-the-clock, long-term opioid treatment.

Opioids are a class of drugs that includes not only powerful prescription painkillers like morphine, oxycodone and fentanyl but also heroin. (Reporting by Natalie Grover in Bangalore; Editing by Saumyadeb Chakrabarty)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below